A detailed history of Turtle Creek Wealth Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Turtle Creek Wealth Advisors, LLC holds 10,532 shares of NVO stock, worth $727,971. This represents 0.11% of its overall portfolio holdings.

Number of Shares
10,532
Holding current value
$727,971
% of portfolio
0.11%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 01, 2025

BUY
$69.3 - $90.95 $729,867 - $957,885
10,532 New
10,532 $731 Million
Q4 2023

Jan 26, 2024

BUY
$87.78 - $105.45 $2,457 - $2,952
28 New
28 $2.9 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $156B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Turtle Creek Wealth Advisors, LLC Portfolio

Follow Turtle Creek Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Turtle Creek Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Turtle Creek Wealth Advisors, LLC with notifications on news.